Scarica l'app Stockscreener
139.42
1.02%
1.601
Precedente Chiudi:
$137.82
Aprire:
$139.15
Volume 24 ore:
37,057
Relative Volume:
0.03
Capitalizzazione di mercato:
$19.06B
Reddito:
$1.53B
Utile/perdita netta:
$-214.69M
Rapporto P/E:
-79.22
EPS:
-1.76
Flusso di cassa netto:
$-43.68M
1 W Prestazione:
-2.90%
1M Prestazione:
-19.00%
6M Prestazione:
-16.94%
1 anno Prestazione:
+31.22%
Intervallo 1D:
$138.15
$139.92
Intervallo di 1 settimana:
$136.96
$144.07
Portata 52W:
$92.14
$183.00
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Confronta NTRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
139.60 | 19.11B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
473.89 | 161.42B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
201.34 | 135.99B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
538.04 | 42.78B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
202.06 | 31.85B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
121.51 | 33.01B | 6.63B | 1.17B | 1.19B | 4.05 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Natera(NTRA) Plunges 1.50% Amid Insider Sales - AInvest
Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
What analysts say about Natera Inc. stockSuperior trading gains - Autocar Professional
SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera CFO Brophy sold $83,852 in NTRA stock By Investing.com - Investing.com Nigeria
Natera CEO Chapman sells $225,928 in shares - Investing.com
Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia
Natera president Fesko sells $273k in stock - Investing.com Australia
Natera Inc: President Moshkevich sells $299k in shares - Investing.com
Natera’s chief legal officer sells $3.4 million in stock - Investing.com
What drives Natera Inc. stock priceMarket-beating returns - jammulinksnews.com
Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Natera director Sheena Jonathan sells $460k in stock By Investing.com - Investing.com Nigeria
Natera director Sheena Jonathan sells $460k in stock - Investing.com
Natera(NTRA) Shares Plunge 3.12% Amid Market, Regulatory Challenges - AInvest
When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com
Natera(NTRA) Shares Plunge 9.16% Amid Regulatory Hurdles - AInvest
What makes Natera Inc. stock price move sharplySafety First Trading Signals - beatles.ru
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera's $234M Trading Volume Ranks 433rd Amid Market Challenges - AInvest
Special master to decide whether Quinn Emanuel lawyers must contribute to $3M sanction - ABA Journal
Natera, Inc. (NTRA): A Bull Case Theory - Insider Monkey
Is Natera (NASDAQ:NTRA) Using Too Much Debt? - 富途牛牛
Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360
US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters
Mike Brophy is regarded as one of Austin's best CFOs - The Business Journals
Natera's 'Signatera' detects recurrence of cancer through a blood test - Fox Business
Natera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Natera Rings the Opening Bell - Nasdaq
Natera presents data from Latitude MRD assay study at ESMO Congress - TipRanks
Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer - New Castle News
Should You Invest in Natera (NTRA)? - Insider Monkey
Bankruptcy Judge Lets Del. Court Take Invitae Contract Fight - Law360
Natera Inks $8.25M Deal To End Prenatal Tests Suit - Law360
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD - Yahoo Finance
Natera, Inc.(NasdaqGS: NTRA) dropped from Russell 2500 Growth Index - MarketScreener
Q1 Immuno-Oncology Earnings Review: First Prize Goes to Natera (NASDAQ:NTRA) - Yahoo Finance
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Natera Inc Azioni (NTRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chapman Steven Leonard | CEO AND PRESIDENT |
Jul 21 '25 |
Sale |
139.29 |
1,622 |
225,928 |
175,492 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Jun 18 '25 |
Sale |
170.18 |
10,000 |
1,701,795 |
213,674 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Jun 20 '25 |
Sale |
170.83 |
9,908 |
1,692,582 |
203,766 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Jul 21 '25 |
Sale |
139.29 |
464 |
64,631 |
204,158 |
| Sheena Jonathan | CO-FOUNDER |
Jul 21 '25 |
Sale |
139.29 |
93 |
12,954 |
245,801 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
May 27 '25 |
Sale |
156.85 |
1,649 |
258,646 |
128,556 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Jul 21 '25 |
Sale |
139.29 |
291 |
40,533 |
128,265 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
May 27 '25 |
Sale |
156.85 |
1,438 |
225,551 |
153,799 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Jul 21 '25 |
Sale |
139.29 |
339 |
47,219 |
153,460 |
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):